Basic Metabolic Panel
Links shared publicly online about this topic
Analyze this basic metabolic panel " db's Medical Rants
medrants.com — “26-year-old man comes in for flank pain. He has a history of renal stones. It is August in Alabama, he has been working outside. He does state that he has been drinking and urinating. Na 139 Cl 92” View full resource at medrants.com
Most Recently Shared on August 5, 2010 at 1:35 am By:
Robert Centor Doctor, Internist, and Physician
Medrants: Analyze this basic metabolic panel http://is.gd/e3hfA
The analysis of the basic metabolic panel " db's Medical Rants
medrants.com — “To repeat the problem: 26-year-old man comes in for flank pain. He has a history of renal stones. It is August in Alabama, he has been working outside. He does state that he has been drinking and urinating.” View full resource at medrants.com
Most Recently Shared on August 7, 2010 at 11:33 am By:
Robert Centor Doctor, Internist, and Physician
Medrants: The analysis of the basic metabolic panel http://is.gd/e7ll3
FDA panel fails to endorse lorcaserin | theheart.org theHeart.org: Lipid and Metabolic news related to heart conditions.
theheart.org — “Studies and Clinical trials on Metabolic and Lipid issues affecting the heart. Articles by heartwire staff and renowned cardiologists. Partnership with Baylor.” View full resource at theheart.org
Most Recently Shared on September 17, 2010 at 3:04 pm By:
FDA panel fails to endorse weight loss drug lorcaserin: Lorcaserin fails to win the endorsement of an FDA panel, w... http://bit.ly/cT4ZMp
This Week: Endocrinologic & metabolic drugs advisory panel of the FDA will review anti-obesity drug Contrave on Tuesday. http://j.mp/gWDKtv
fda.gov — “This Week: Endocrinologic & metabolic drugs advisory panel of the FDA will review anti-obesity drug Contrave on Tuesday. http://j.mp/gWDKtv” View full resource at fda.gov
Most Recently Shared on December 6, 2010 at 7:04 pm By:
Hisham Rana, MD Doctor and Physician
This Week: Endocrinologic & metabolic drugs advisory panel of the FDA will review anti-obesity drug Contrave on Tuesday. http://j.mp/gWDKtv
Meridia risks warrant restrictions or withdrawal: FDA panel | theheart.org theHeart.org: Lipid and Metabolic news related to heart conditions.
theheart.org — “Studies and Clinical trials on Metabolic and Lipid issues affecting the heart. Articles by heartwire staff and renowned cardiologists. Partnership with Baylor.” View full resource at theheart.org
Most Recently Shared on September 15, 2010 at 9:06 pm By:
FDA advisors say sibutramine's CV risks warrant harsher restrictions or withdrawal: Six members of the FDA panel v... http://bit.ly/alR58l
HCV New Drug Research: Hepatitis C; Understanding the Basic Metabolic Profile (BMP)
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Hepatitis C; Understanding the Basic Metabolic Profile (BMP)” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on April 15, 2011 at 12:45 am By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Hepatitis C; Understanding the Basic Metabolic Profile (BMP) http://goo.gl/fb/m3JVY
Basal Metabolic Rate (BMR) Calculator - Toolkit -EverydayHealth.com
everydayhealth.com — “Basal Metabolic Rate (BMR) Calculator - Toolkit -EverydayHealth.com” View full resource at everydayhealth.com
Most Recently Shared on September 2, 2010 at 10:00 pm By:
Your BMR rate is the calories you burn without even lifting a finger (lucky you!). Here’s how to figure out yours: http://ow.ly/2y7hS
FDA panel to review diet drugs | theheart.org
theheart.org — “The FDA's Endocrinologic and Metabolic Drugs Advisory Committee will review the CV outcomes data from SCOUT for sibutramine, and weigh the new drug application for lorcaserin.” View full resource at theheart.org
Most Recently Shared on August 9, 2010 at 10:25 pm By:
Sibutramine CV safety, lorcaserin, up for FDA review: The FDA's Endocrinologic and Metabolic Drugs Advisory Commit... http://bit.ly/bBPd6l
Obesity Drug, Contrave Gets Green Light From FDA Advisory Panel
medicalnewstoday.com — “Experimental drug Contrave(R) (naltrexone SR/bupropion SR) for the treatment of obesity has been recommended for approval by the FDA's Endocrinologic and Metabolic Drugs Advisory Committee. The Co” View full resource at medicalnewstoday.com
Most Recently Shared on December 8, 2010 at 6:01 pm By:
Obesity Drug, Contrave Gets Green Light From FDA Advisory Panel Experimental drug Contrave(R) (naltrexone SR/bupropion .. http://dld.bz/9Ufx
What is Insulin Resistance? Basic Facts and Tips for Prevention
suite101.com — “Learn more about insulin resistance, related conditions, and its link to metabolic syndrome and pre-diabetes and how it might be reversed.” View full resource at suite101.com
Most Recently Shared on December 28, 2010 at 12:44 pm By:
What is Insulin Resistance? Basic Facts and Tips for Prevention: Learn more about insulin resistance, related co... http://bit.ly/fRaJJz
Effect of Atorvastatin on CYP2C9 Metabolic Activity as Measured by the Formation Rate of Losartan Metabolite in Hypercholesterolaemic Patients - Yasar - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
onlinelibrary.wiley.com — “Effect of Atorvastatin on CYP2C9 Metabolic Activity as Measured by the Formation Rate of Losartan Metabolite in Hypercholesterolaemic Patients - Yasar - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on February 18, 2011 at 7:43 pm By:
Drugs and Devices OW OW Health
Effect of Atorvastatin on CYP2C9 Metabolic Activity as Measured by the Formation Rate of Losartan Metabolite in ... http://bit.ly/g22K4o
Metabolic disarray — db's Medical Rants
medrants.com — “47-year-old woman found stuporous and hypotensive. She has known alcohol abuse and decreased LVEF around 30%. Her labs come back, and you should provide plausible reconstructions of these results. Fluid Balance Panel 110 59 38 73 3.2 30” View full resource at medrants.com
Most Recently Shared on August 30, 2011 at 10:51 pm By:
Robert Centor Doctor, Internist, and Physician
Medrants: Metabolic disarray http://t.co/dNFS5D1
ZenBio Licenses An Important Cell Line From Harvard To Drive Metabolic Disease Research
medicalnewstoday.com — “ZenBio announce that they will be a commercial source for the popular murine 3T3-L1 cell line, which has been fundamental in metabolic disease research for 30 years. Originally derived from Swiss” View full resource at medicalnewstoday.com
Most Recently Shared on March 11, 2010 at 3:37 am By:
ZenBio Licenses An Important Cell Line From Harvard To Drive Metabolic Disease Research ZenBio announce that they wil.. http://bit.ly/bYj43N
FDA panel to vote on efficacy, safety of fenofibric acid
endocrinetoday.com — “The FDA Endocrinologic and Metabolic Drugs Advisory Committee will today discuss the future of fenofibric acid. The panel is expected to vote w” View full resource at endocrinetoday.com
Most Recently Shared on May 19, 2011 at 2:14 pm By:
Today the FDA panel will vote on safety, efficacy of fenofibric acid. http://bit.ly/iSNdGM Stay tuned for the results!
Gestational Diabetes Underdiagnosed - Diabetes Mellitus, Type 2 Diabetes, Type 1, and Metabolic Disorders Treatment and Medications on MedicineNet.com
medicinenet.com — “Medical information about Diabetes Mellitus, Type 2, Type 1, and Metabolic Disorders treatment and medications.” View full resource at medicinenet.com
Most Recently Shared on April 8, 2010 at 10:16 am By:
Panel Calls for Changes That Could Triple Cases of Gest Diabetes (based on 23,000 women over 10yrs) http://tinyurl.com/yzkbypb
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Robert Centor
Academic internist focusing on teaching
-
Robert Centor
Academic internist focusing on teaching
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
Advertisement
